ArticleInternational journal of colorectal disease2023

Intraperitoneal paclitaxel combined with FOLFOX/CAPOX plus bevacizumab for colorectal cancer with peritoneal carcinomatosis (the iPac-02 trial): study protocol of a single arm, multicenter, phase 2 study.

Koji Murono et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.